Fundrise Innovation Fund's stock price has increased for the fourth consecutive day, soaring 1,300% above its net asset value.

LootboxPhobia · 2026-03-24T23:01:31+00:00

Fundrise Innovation Fund shares recently surged 39%, with gains exceeding 1300% in early trading. The fund invests in companies preparing for IPO such as SpaceX and OpenAI, with most shares subject to lock-up agreements that prohibit early investors from selling within six months after the companies go public.

LootboxPhobia

2026-03-24 23:01:31

Abstract generation in progress

Investing.com - The Fundrise Innovation Fund’s stock price surged as much as 39% to $265 per share on Tuesday, marking the fourth day of trading for this newly listed closed-end fund. Due to high volatility, trading was paused multiple times.

The fund’s ticker symbol is VCX. Since its market debut last week, its share price has soared over 1,300% above its net asset value. Investors’ bids for this limited-supply stock are more than 13 times the fund’s latest net asset value of $18.97 per share.

The fund holds shares of companies preparing for IPO, including SpaceX and Anthropic PBC. Its portfolio also includes stakes in OpenAI Inc., Anduril Industries Inc., Databricks Inc., and Ramp Inc.

According to filings with the U.S. Securities and Exchange Commission, the Fundrise Innovation Fund, after nearly five years of operation, proposes to become a publicly listed closed-end fund to create potential value and improve liquidity.

Most of the fund’s shares remain subject to lock-up agreements. The filings show that for approximately 100,000 investors who purchased shares before the market debut, shares bought before February 20 are prohibited from being sold within six months of listing.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.